No scam in vectracide purchase: EDMC

Image
Press Trust of India New Delhi
Last Updated : Mar 17 2016 | 9:32 PM IST
East Delhi Municipal Corporation today rubbished Delhi government's charge of scam in purchase of pesticide to control dengue vector.
The matter was raised in the EDMC meeting, where standing committee chairman Lata Gupta rubbished the charge.
"There is no scam in purchase of the pesticide to control dengue vector. Contrary to SDMC and NDMC, we purchased lesser quantity of it. While SDMC and NDMC purchased around 4000 tonnes of it, we purchased only 40 tonnes which is one reason why cost was higher," she said.
Earlier in the day, Delhi Water Minister Kapil Mishra alleged a "scam" in the purchase of dengue vector control chemical 'vectracide' by BJP-ruled EDMC at a "higher rate" than South Delhi and North Delhi Municipal Corporations.
"Massive scam in EDMC in purchase of dengue medicines. Same medicines were purchased by NDMC and SDMC at cheaper rates from same vendor," he tweeted.
"Scam in EDMC - Vectracide is the medicine that was purchased at Rs 875 per kg by EDMC while same was purchased by NDMC at Rs 675 per kg," he said.
Gupta added that EDMC not only purchased the pesticide two months before the other two civic bodies, it also did not pay any consultancy charge for purchase which was paid by them.
"The purchase was made through open tender process duly concurred by finance department and approval of the standing committee," EDMC additional Commissioner Pawan Sharma added.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 17 2016 | 9:32 PM IST

Next Story